Edward J. Dulac III is CFO at FATE THERAPEUTICS INC (FATE). They have made 11 open-market trades across 2 companies since 2021, most recently 2026-07-22.
CIK 0001821530
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NTLA | 148,175 | $1.7M |
| FATE | 101,479 | $181K |
| Total | $1.9M |
Shares reported on the most recent Form 4, priced at the 2026-07-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NTLA | SELL | 2026-07-22 | 2026-07-24 | $11.25 | $91K | -1.2% | +13.2% | — |
| NTLA | SELL · 10b5-1 | 2026-07-02 | 2026-07-06 | $18.00 | $84K | -33.8% | -38.8% | -28.7% |
| NTLA | SELL | 2026-01-05 | 2026-01-07 | $9.21 | $59K | +19.7% | +14.6% | +26.5% |
| NTLA | SELL | 2025-07-23 | 2025-07-25 | $14.02 | $209K | -16.9% | -16.8% | +89.3% |
| FATE | SELL · 10b5-1 | 2024-03-04 | 2024-03-05 | $7.77 | $19K | +4.6% | -2.7% | -48.7% |
| FATE | SELL · 10b5-1 | 2024-01-29 | 2024-01-30 | $5.00 | $9K | +13.9% | +28.4% | -26.8% |
| FATE | SELL | 2024-01-09 | 2024-01-10 | $4.37 | $31K | +7.6% | +40.1% | +50.6% |
| FATE | SELL · 10b5-1 | 2024-01-02 | 2024-01-03 | $3.66 | $19K | +27.0% | +83.7% | +91.5% |
| FATE | SELL · 10b5-1 | 2023-12-18 | 2023-12-19 | $3.50 | $6K | +13.5% | +33.2% | +116.6% |
| FATE | SELL | 2023-08-18 | 2023-08-21 | $2.80 | $13K | -8.7% | -18.2% | -5.5% |
| FATE | SELL · 10b5-1 | 2023-07-05 | 2023-07-06 | $4.83 | $25K | -1.9% | -24.1% | -62.4% |
| FATE | SELL | 2023-01-10 | 2023-01-11 | $5.24 | $38K | -5.2% | +8.6% | -1.6% |
| FATE | SELL | 2022-08-18 | 2022-08-19 | $29.78 | $293K | -7.2% | -10.2% | -28.6% |
| FATE | SELL | 2022-01-11 | 2022-01-13 | $48.45 | $86K | -5.3% | -12.2% | -6.1% |
| FATE | SELL | 2021-12-20 | 2021-12-21 | $60.00 | $959K | -4.5% | -39.4% | -40.3% |
| FATE | SELL | 2021-09-28 | 2021-09-30 | $62.53 | $2.4M | -1.0% | -3.2% | -0.7% |
| FATE | SELL | 2021-08-19 | 2021-08-20 | $88.24 | $608K | +11.3% | -0.7% | -18.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.